Found 26 matching trials
Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer PHASE2 Background:
\- Enzalutamide is a well tolerated hormone therapy that is us...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer PHASE1 This study study aims to elucidate the immune responses to a shared antigen...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer PHASE2 Background:
* Flutamide is an approved drug for prostate cancer that block...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer PHASE2 This study will test the ability of an experimental vaccine to increase the...
Show More Location
National Cancer Institute (NCI), 9000 Rockville Pike
Learn More & Join Trial
Sequential Vaccinations in Prostate Cancer Patients PHASE1 Background:
" Adenocarcinoma of the prostate is the most common cancer dia...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer PHASE2 This study is a prospective, open label, single arm phase II trial. A total...
Show More Location
Huntsman Cancer Institute
Learn More & Join Trial
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer PHASE2 Vaccines made from a gene-modified virus may help the body build an effecti...
Show More Location
Baptist Cancer Institute
Learn More & Join Trial
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer PHASE1 Background:
The immune system is the cells and organs in the body that rec...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer PHASE2 Background:
Metastatic castrate-sensitive prostate cancer is cancer that h...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy PHASE2 The purpose of this study is to see how well PROSTVAC -V/F works in stoppin...
Show More Location
Medical University of South Carolina
Learn More & Join Trial